Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Canopy Growth Corporation - Common Shares (NQ:CGC)

1.130 -0.060 (-5.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Canopy Growth Corporation - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday?
Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year. 
Via Benzinga
Topics Cannabis
What's going on in today's pre-market session
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Canopy Gwth Q3 Earnings Assessment
Via Benzinga
Earnings Scheduled For February 7, 2025
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks. 
Via Benzinga
Topics Cannabis
Can Canada Maintain Its Cannabis Edge After Trudeau's Departure?
Trudeau's exit leaves Canada's cannabis industry at a crossroads. Will new leadership support its growth? 
Via Benzinga
Topics Cannabis
The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And More
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates. 
Via Benzinga
Topics Cannabis Government
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
Cannabis news of the week: New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more. 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers. 
Via Benzinga
Topics Cannabis
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know
Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQ: CGC) U.S.-domiciled holding... 
Via Benzinga
Topics Cannabis
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK. 
Via Benzinga
Topics Cannabis
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in. 
Via Benzinga
Topics Cannabis
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic. 
Via Benzinga
Topics Cannabis
Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Losses
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) and Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF) announced on Monday that it is anticipated that Canopy USA, LLC will... 
Via Benzinga
Topics Cannabis
Cannabis Retailer Tokyo Smoke Moves Forward After Major Restructuring
Cannabis retailer Tokyo Smoke has finished its restructuring process and is no longer under financial protection, following a court's approval. The Canadian company first announced that it started... 
Via Benzinga
Topics Cannabis
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal
Via Benzinga
Canopy USA's Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholders
Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQ: CGC) strategy for capturing the U.S.... 
Via Benzinga
Topics Cannabis
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders. 
Via Benzinga
Topics Cannabis
Canopy Growth Names New CEO Who Will Succeed David Klein Amid US Expansion
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Tuesday its board of directors has named Luc Mongeau as the company's next chief executive officer, effective Jan. 6, 2025.Mongeau, a... 
Via Benzinga
Topics Cannabis
The Canadian Cannabis Report - Monday, Nov 25
The past, present and future of the Canadian cannabis sector 
Via Talk Markets
Topics Cannabis ETFs Stocks / Equities
Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supply
Via Benzinga
Topics Cannabis
What's Happening With Canopy Growth: Is It Time To Buy?
Canopy Growth (NASDAQ: CGC) hovers near $3.93. Fibonacci levels suggest key resistance at $6.36 and support at $3.86. Is it worth the risk? 
Via Benzinga
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion. 
Via Benzinga
Topics Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty. 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback